Завершено
Фаза III
Россия
Paclitaxel; NOV-002; Carboplatin · Cellectar Biosciences, Inc.
Phase 3 Trial, Randomized, Open-Label, of NOV-002 in Combination With Paclitaxel and Carboplatin vs. Paclitaxel and Carboplatin Alone for the Treatment of Advanced Non-Small-Cell Lung Cancer (NSCLC)